WASHINGTON, April 27 (Reuters) - The White House is
considering options for maximizing production and supply of
COVID-19 vaccines for the world at the lowest cost, including
backing a proposed waiver of intellectual property rights, but
no decision has been made, press secretary Jen Psaki said on
Tuesday.
"There are a lot of different ways to do that. Right now,
that's one of the ways, but we have to assess what makes the
most sense," Psaki said, adding that U.S. officials were also
looking at whether it would be more effective to boost
manufacturing in the United States.
(Reporting by Steve Holland and Andrea Shalal; Editing by
Leslie Adler)